AN OVERVIEW OF ESSENTIAL STUDIES AND PROGNOSIS OF BREAST CANCER WITH THEIR ADVERSE EFFECTS

CH. Sravanthi*, A. Bhargavi and P. Gayatri Devi

Breast cancer ranks among the most recurrent cancers affecting women globally, defined by the uncontrolled proliferation of breast cancer. This review examines the epidemiology, medicine interactions between treatment and cell target, contemporary treatment approaches to breast cancer & incidence rates worldwide, with higher occurrences in developed nations. Significant causing factors include genetic mutations (notably BRCA1 and BRCA2), hormonal factors, lifestyle choices, and environmental exposures. Available treatment methods comprise surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapies, with a growing focus on personalized medicine. Despite progress in early detection and treatment, disparities in healthcare access and outcomes persist. Molecular biology advancements have revealed crucial pathways in breast cancer development, such as the roles of estrogen receptors, HER2/neu, is a gene that encodes the human epidermal growth factor receptor2, a protein involved in cell growth and differentiation, amplification of this gene can play a crucial role in the development and progression glands of certain aggressive types of breast cancer and other growth factor receptors). This review highlights the necessity for ongoing clinical research, ongoing treatment with line of medication, ongoing procedures with equipment, and innovation to enhance the prognosis and quality of life for breast cancer patients.